<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940705-2-00161</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q&hyph;II&hyph;D&hyph;2&hyph;p. Restraining devices for animals may be required to avoid  <!-- PJG 0012 frnewline --> damage to the integrity of the containment animal facility.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix Q&hyph;II&hyph;D&hyph;2&hyph;q. The supply water distribution system shall be fitted with a  <!-- PJG 0012 frnewline --> back-flow preventer or break tank.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix Q&hyph;II&hyph;D&hyph;2&hyph;r. All utilities, liquid and gas services, shall be protected with  <!-- PJG 0012 frnewline --> devices that avoid back-flow.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix Q&hyph;II&hyph;D&hyph;2&hyph;s. Sewer and other atmospheric ventilation lines shall be  <!-- PJG 0012 frnewline --> equipped minimally with a single high efficiency particulate/HEPA filter.  <!-- PJG 0012 frnewline --> Condensate drains from these type housings shall be appropriately connected to a  <!-- PJG 0012 frnewline --> contaminated or sanitary drain system. The drain position in the housing dictates  <!-- PJG 0012 frnewline --> the appropriate system to be used.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix Q&hyph;III. Footnotes and References for Appendix Q  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q&hyph;III&hyph;A. If recombinant DNA is derived from a Class 2 organism  <!-- PJG 0012 frnewline --> requiring BL2 containment, personnel shall be required to have specific training in  <!-- PJG 0012 frnewline --> handling pathogenic agents and directed by knowledgeable scientists.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix Q&hyph;III&hyph;B. Personnel who handle pathogenic and potentially lethal agents  <!-- PJG 0012 frnewline --> shall be required to have specific training and be supervised by knowledgeable  <!-- PJG 0012 frnewline --> scientists who are experienced in working with these agents. BL3&hyph;N containment  <!-- PJG 0012 frnewline --> also minimizes escape of recombinant DNA-containing organisms from exhaust air  <!-- PJG 0012 frnewline --> or waste material from the containment area.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix Q&hyph;III&hyph;C. Classes 4 and 5 microorganisms pose a high level of individual  <!-- PJG 0012 frnewline --> risk for acquiring life-threatening diseases to personnel and/or animals. To import  <!-- PJG 0012 frnewline --> Class 5 agents, special approval must be obtained from U.S. Department of  <!-- PJG 0012 frnewline --> Agriculture, Animal and Plant Health Inspection Service, Import-Export Products,  <!-- PJG 0012 frnewline --> Room 756, Federal Building, 6505 Belcrest Road, Hyattsville, Maryland 20782.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Laboratory staff shall be required to have specific and thorough training in  <!-- PJG 0012 frnewline --> handling extremely hazardous infectious agents, primary and secondary  <!-- PJG 0012 frnewline --> containment, standard and special practices, and laboratory design characteristics.  <!-- PJG 0012 frnewline --> The laboratory staff shall be supervised by knowledgeable scientists who are  <!-- PJG 0012 frnewline --> trained and experienced in working with these agents and in the special  <!-- PJG 0012 frnewline --> containment facilities.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Within work areas of the animal facility, all activities shall be confined to the  <!-- PJG 0012 frnewline --> specially equipped animal rooms or support areas. The maximum animal  <!-- PJG 0012 frnewline --> containment area and support areas shall have special engineering and design  <!-- PJG 0012 frnewline --> features to prevent the dissemination of microorganisms into the environment via  <!-- PJG 0012 frnewline --> exhaust air or waste disposal.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix Q&hyph;III&hyph;D. Other research with non-laboratory animals, which may not  <!-- PJG 0012 frnewline --> appropriately be conducted under conditions described in Appendix Q, may be  <!-- PJG 0012 frnewline --> conducted safely by applying practices routinely used for controlled culture of these  <!-- PJG 0012 frnewline --> biota. In aquatic systems, for example, BL1 equivalent conditions could be met by  <!-- PJG 0012 frnewline --> utilizing growth tanks that provide adequate physical means to avoid the escape of  <!-- PJG 0012 frnewline --> the aquatic species, its gametes, and introduced exogenous genetic material. A  <!-- PJG 0012 frnewline --> mechanism shall be provided to ensure that neither the organisms nor their  <!-- PJG 0012 frnewline --> gametes can escape into the supply or discharge system of the rearing container  <!-- PJG 0012 frnewline --> (e.g., tank, aquarium, etc.) Acceptable barriers include appropriate filtration,  <!-- PJG 0012 frnewline --> irradiation, heat treatment, chemical treatment, etc. Moreover, the top of the  <!-- PJG 0012 frnewline --> rearing container shall be covered to avoid escape of the organism and its gametes.  <!-- PJG 0012 frnewline --> In the event of tank rupture, leakage, or overflow, the construction of the room  <!-- PJG 0012 frnewline --> containing these tanks should prevent the organisms and gametes from entering the  <!-- PJG 0012 frnewline --> building's drains before the organism and its gametes have been inactivated.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Other types of non-laboratory animals (e.g., nematodes, arthropods, and certain  <!-- PJG 0012 frnewline --> forms of smaller animals) may be accommodated by using the appropriate BL1  <!-- PJG 0012 frnewline --> through BL4 or BL1&hyph;P through BL4&hyph;P containment practices and procedures as  <!-- PJG 0012 frnewline --> specified in Appendices G and P. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> OMB's ``Mandatory Information Requirements for Federal Assistance Program  <!-- PJG 0012 frnewline --> Announcements'' (45 FR 39592) requires a statement concerning the official  <!-- PJG 0012 frnewline --> government programs contained in the Catalog of Federal Domestic Assistance.  <!-- PJG 0012 frnewline --> Normally NIH lists in its announcements the number and title of affected  <!-- PJG 0012 frnewline --> individual programs for the guidance of the public. Because the guidance in this  <!-- PJG 0012 frnewline --> notice covers not only virtually every NIH program but also essentially every  <!-- PJG 0012 frnewline --> Federal research program in which DNA recombinant molecule techniques could  <!-- PJG 0012 frnewline --> be used, it has been determined to be not cost effective or in the public interest to  <!-- PJG 0012 frnewline --> attempt to list these programs. Such a list would likely require several additional  <!-- PJG 0012 frnewline --> pages. In addition, NIH could not be certain that every Federal program would be  <!-- PJG 0012 frnewline --> included as many Federal agencies, as well as private organizations, both national  <!-- PJG 0012 frnewline --> and international, have elected to follow the NIH Guidelines. In lieu of the  <!-- PJG 0012 frnewline --> individual program listing, NIH invites readers to direct questions to the  <!-- PJG 0012 frnewline --> information address above about whether individual programs listed in the Catalog  <!-- PJG 0012 frnewline --> of Federal Domestic Assistance are affected. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Effective Date: June 24, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Harold Varmus, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Director, National Institutes of Health.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;16199 Filed 7&hyph;1&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4140&hyph;01&hyph;P <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            